Despite Fast-paced Momentum, Precision BioSciences (DTIL) Is Still a Bargain Stock

Core Viewpoint - Momentum investing focuses on "buying high and selling higher," contrasting with traditional strategies of "buying low and selling high" [1] Group 1: Momentum Investing Strategy - Momentum investing can be risky as stocks may lose momentum if their valuations exceed future growth potential [1] - Identifying the right entry point for momentum stocks is challenging, leading to potential losses if the stock price does not continue to rise [1] Group 2: Investment Opportunities - Investing in bargain stocks that have recently shown price momentum can be a safer strategy [2] - The Zacks Momentum Style Score is useful for identifying strong momentum stocks, while the 'Fast-Paced Momentum at a Bargain' screen helps find attractively priced fast-moving stocks [2] Group 3: Precision BioSciences (DTIL) Analysis - Precision BioSciences (DTIL) has seen a price increase of 14.5% over the past four weeks, indicating growing investor interest [3] - DTIL has gained 1.5% over the past 12 weeks, demonstrating its ability to deliver positive returns over a longer timeframe [4] - The stock has a beta of 1.7, suggesting it moves 70% more than the market in either direction, indicating fast-paced momentum [4] Group 4: Valuation and Earnings Estimates - DTIL has a Momentum Score of A, suggesting it is an opportune time to invest in the stock [5] - The stock has a Zacks Rank 1 (Strong Buy) due to upward revisions in earnings estimates, which typically attract more investors [6] - DTIL is trading at a Price-to-Sales ratio of 0.85, indicating it is relatively cheap at 85 cents for each dollar of sales [6] Group 5: Additional Investment Options - Besides DTIL, there are other stocks that meet the criteria of the 'Fast-Paced Momentum at a Bargain' screen, presenting further investment opportunities [7] - Zacks offers over 45 Premium Screens tailored to different investing styles, which can help identify winning stock picks [8]